IceCure's Advanced Multiprobe Cryoablation Technology Receives Patent Approval in Japan
November 25, 2024 - 22:01
IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
MORE NEWS
May 17, 2026 - 19:03
Derek Advanced Tracking Systems Revolutionizes Asset Monitoring with Advanced TechnologyAsset owners no longer have to rely on outdated GPS pings or hope that a pricey piece of equipment will stay put. Derek Advanced Tracking Systems has rolled out a new generation of monitoring tools...
May 17, 2026 - 04:33
Institutional investors boost Micron Technology, Intel stocks in Q1Institutional investors significantly increased their exposure to Micron Technology and Intel during the first quarter of 2026, signaling renewed confidence in the semiconductor sector. Data shows...
May 16, 2026 - 00:04
ASU joins Applied Materials' EPIC Center as inaugural university research partnerWhen the United States decided in 2020 to reinvest in domestic semiconductor manufacturing, it faced a paradox built into capitalism itself. How do you create the collaborative environment needed...
May 15, 2026 - 03:31
Reps. Davis, Tenney push for genetically targeted heart disease technologiesA bipartisan effort in the House is aiming to accelerate the development and availability of genetically targeted technologies for heart disease. Representatives Don Davis, a Democrat from North...